Do children benefit from mass screening for neuroblastoma?
- 1 February 1991
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 337 (8737) , 344-346
- https://doi.org/10.1016/0140-6736(91)90957-q
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.Journal of Clinical Oncology, 1990
- Problems of mass screening for neuroblastoma: Analysis of false-negative casesJournal of Pediatric Surgery, 1990
- Improvement in prognosis of neuroblastoma through mass population screeningJournal of Pediatric Surgery, 1990
- Cases of Neuroblastoma Missed by the Mass Screening ProgramsPediatric Research, 1989
- Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1Cancer, 1989
- Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10-year retrospective studyCancer, 1988
- Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screeningThe Journal of Pediatrics, 1988
- Effects of the mass screening of neuroblastoma in sapporo cityCancer, 1987
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984